Smilow Cancer Hospital Phase 1 Unit — New Haven, Connecticut

Smilow Cancer Hospital Phase 1 Unit is a clinical research site located in New Haven, Connecticut, United States 06511.

Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.

Smilow Cancer Hospital Phase 1 Unit has participated in 12 clinical trials with 6 currently active.

Therapeutic areas: Head and Neck Cancer Squamous Cell Carcinoma, Non-small Cell Lung Cancer, Gastric Cancer.

Sponsors: ADC Therapeutics S.A., Pfizer, Prelude Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New Haven

Browse all research sites in Connecticut · View every site in New Haven

• Yale University, Department of Diagnostic Radiology
• Yale Center for Clinical Investigation, Yale University
• Yale Center for XLH/ Yale University School of Medicine
• Yale University/Yale Cancer Center/Yale School of Medicine
• Yale New Haven Hospital Saint Raphael's Campus
• Yale University School of Medicine; HIV Clinical Trials Program
• Yale University School of Medicine YaleCancerCtr-ClinTrialsOffice
• Yale Cancer Center Smilow Cancer Hospital
• Yale New Haven Hospital Pediatric Dental Center
• Yale University School of Medicine - Department of Neurosurgery
• Yale University Program for Recovery and Community Health
• PET Center, YCCI Hospital Research Unit (HRU)

Sponsor Feasibility Report

Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Smilow Cancer Hospital Phase 1 Unit?

Smilow Cancer Hospital Phase 1 Unit has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Smilow Cancer Hospital Phase 1 Unit conducted?

Smilow Cancer Hospital Phase 1 Unit has 12 clinical trials on record, with 6 currently active. Their work covers Head and Neck Cancer Squamous Cell Carcinoma, Non-small Cell Lung Cancer, Gastric Cancer.

Is Smilow Cancer Hospital Phase 1 Unit accredited by Crixeo Clinical Trials?

Smilow Cancer Hospital Phase 1 Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Smilow Cancer Hospital Phase 1 Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.